3Ross DE,Thomas M,Booth M,et al.Rate of Tardive Dyskinesia in Hospitalized Patients.Am J Psychiatry,2005,162(4):816.
4Gharabawi GM,Bossie CA,Zhu Y.New-Onset Tardive Dyskinesia in Patients With First-Episode Psychosis Receiving Risperidone or Haloperidol.Am J Psychiatry,2006,163 (5):938.
5Andreassen OA,Jorgensen HA.Neurotoxicity associated with neuroleptic-induced oral dyskine-sias in rats.Implications for tardive dyskinesia.Prog Neurobiol,2000,61 (5):525.
6Delfs JM,Ellison GD,Mercugliano M,et al.Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.Exp Neurol,1995,133 (2):175.
7Calabrese V,Guagliano E,Sapienza M,et al.Redox regulation of cellular stress response in ne-urodegenerative disorders.Ital J Biochem,2006,55 (3 -4):263.
8Carter CJ.Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation,oxidative stress and oligodendrocyte viability.Schizophr Res,2006,86 (1 -3):1.
9Kropp S,Kern V,Lange K,et al.Oxidative stress during treatment with first-and second-g-eneration Antipsychotics.J Neuropsychiatry Clin Neurosci,2005,17(2):227.
10I-Ching Lai,Ding-Lieh Liao,Ya-Mei Bai,et al.Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.Neuropsychobiology Basel,2002,46(4):173.
